questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérocycliques 3 noyaux
Acridines
Aminoacridines
Mépacrine
Mépacrine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections parasitaires
Diagnostic médical
Tests de laboratoire
Analyses de sang
Leishmaniose
Maladies auto-immunes
Symptômes
Infections parasitaires
Efficacité du traitement
Suivi médical
Symptômes
5
Effets secondaires
Nausées
Réactions allergiques
Démangeaisons
Troubles digestifs
Diarrhée
Prévention
5
Vaccins
Prévention des infections
Traitements
5
Administration orale
Comprimés
Posologie
Infections parasitaires
Thérapie combinée
Médicaments
Traitements alternatifs
Antiparasitaires
Complications
5
Complications
Troubles hépatiques
Problèmes hématologiques
Anémie
Signes de complications
Saignements
Gestion des complications
Suivi médical
Fréquence des complications
Surveillance médicale
Facteurs de risque
5
Facteurs de risque
Système immunitaire
Antécédents médicaux
Maladies hépatiques
Interactions médicamenteuses
Efficacité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mépacrine : Questions médicales les plus fréquentes",
"headline": "Mépacrine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mépacrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-23",
"dateModified": "2025-04-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mépacrine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Aminoacridines",
"url": "https://questionsmedicales.fr/mesh/D000609",
"about": {
"@type": "MedicalCondition",
"name": "Aminoacridines",
"code": {
"@type": "MedicalCode",
"code": "D000609",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.046.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Moutarde de quinacrine",
"alternateName": "Quinacrine Mustard",
"url": "https://questionsmedicales.fr/mesh/D011797",
"about": {
"@type": "MedicalCondition",
"name": "Moutarde de quinacrine",
"code": {
"@type": "MedicalCode",
"code": "D011797",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.300.046.250.760.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Mépacrine",
"alternateName": "Quinacrine",
"code": {
"@type": "MedicalCode",
"code": "D011796",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Chanakya Nath Kundu",
"url": "https://questionsmedicales.fr/author/Chanakya%20Nath%20Kundu",
"affiliation": {
"@type": "Organization",
"name": "Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India. cnkundu@kiitbiotech.ac.in."
}
},
{
"@type": "Person",
"name": "Thomas R Lane",
"url": "https://questionsmedicales.fr/author/Thomas%20R%20Lane",
"affiliation": {
"@type": "Organization",
"name": "Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, USA."
}
},
{
"@type": "Person",
"name": "Sean Ekins",
"url": "https://questionsmedicales.fr/author/Sean%20Ekins",
"affiliation": {
"@type": "Organization",
"name": "Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, USA peter.madrid@sri.com sean@collaborationspharma.com."
}
},
{
"@type": "Person",
"name": "Biswajit Das",
"url": "https://questionsmedicales.fr/author/Biswajit%20Das",
"affiliation": {
"@type": "Organization",
"name": "Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India."
}
},
{
"@type": "Person",
"name": "Chinmayee Sethy",
"url": "https://questionsmedicales.fr/author/Chinmayee%20Sethy",
"affiliation": {
"@type": "Organization",
"name": "Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Violence and Abuse: A Pandemic Within a Pandemic.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37527378",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5811/westjem.58405"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fighting the obesity pandemic during the COVID-19 pandemic.",
"datePublished": "2022-09-26",
"url": "https://questionsmedicales.fr/article/36163563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00464-022-09628-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Preparing for Pandemics].",
"datePublished": "2023-06-29",
"url": "https://questionsmedicales.fr/article/37385241",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1972-1623"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pandemics and their accelerants",
"datePublished": "2024-05-02",
"url": "https://questionsmedicales.fr/article/38696560",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1126/science.ado3527"
}
},
{
"@type": "ScholarlyArticle",
"name": "The UK's pandemic preparedness and early response to the COVID-19 pandemic.",
"datePublished": "2024-10-21",
"url": "https://questionsmedicales.fr/article/39432455",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17441692.2024.2415499"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérocycliques 3 noyaux",
"item": "https://questionsmedicales.fr/mesh/D006575"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acridines",
"item": "https://questionsmedicales.fr/mesh/D000166"
},
{
"@type": "ListItem",
"position": 6,
"name": "Aminoacridines",
"item": "https://questionsmedicales.fr/mesh/D000609"
},
{
"@type": "ListItem",
"position": 7,
"name": "Mépacrine",
"item": "https://questionsmedicales.fr/mesh/D011796"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mépacrine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mépacrine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mépacrine",
"description": "Comment diagnostiquer une infection nécessitant la mépacrine ?\nQuels tests sont utilisés pour la mépacrine ?\nLa mépacrine est-elle utilisée pour des maladies spécifiques ?\nQuels symptômes indiquent un besoin de mépacrine ?\nComment évaluer l'efficacité de la mépacrine ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Pandemics#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mépacrine",
"description": "Quels sont les effets secondaires courants de la mépacrine ?\nLa mépacrine peut-elle provoquer des réactions allergiques ?\nQuels symptômes indiquent une surdose de mépacrine ?\nLa mépacrine affecte-t-elle le système digestif ?\nQuels signes d'infection nécessitent un traitement par mépacrine ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Pandemics#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mépacrine",
"description": "Comment prévenir les infections traitées par mépacrine ?\nLes voyages dans certaines zones augmentent-ils le risque d'infection ?\nDes vaccins existent-ils pour prévenir les infections ?\nComment réduire le risque de piqûres de moustiques ?\nLa mépacrine peut-elle être utilisée en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Pandemics#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mépacrine",
"description": "Comment la mépacrine est-elle administrée ?\nQuelle est la posologie standard de mépacrine ?\nLa mépacrine est-elle efficace contre tous les parasites ?\nPeut-on combiner la mépacrine avec d'autres traitements ?\nQuels sont les traitements alternatifs à la mépacrine ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Pandemics#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mépacrine",
"description": "Quelles complications peuvent survenir avec la mépacrine ?\nLa mépacrine peut-elle causer des problèmes hématologiques ?\nQuels signes indiquent une complication grave ?\nComment gérer les complications liées à la mépacrine ?\nLes complications sont-elles fréquentes avec la mépacrine ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Pandemics#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mépacrine",
"description": "Quels facteurs augmentent le risque d'infection ?\nL'âge influence-t-il le risque d'effets secondaires ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe sexe influence-t-il la réponse à la mépacrine ?\nLes interactions médicamenteuses sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Pandemics#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection nécessitant la mépacrine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests de laboratoire pour identifier les parasites."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la mépacrine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de selles peuvent être effectués."
}
},
{
"@type": "Question",
"name": "La mépacrine est-elle utilisée pour des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour traiter la leishmaniose et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de mépacrine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fièvre, des douleurs abdominales et des éruptions cutanées peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité de la mépacrine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la réduction des symptômes et des résultats de tests de suivi."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants de la mépacrine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des nausées, des vomissements et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La mépacrine peut-elle provoquer des réactions allergiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques comme des démangeaisons ou un gonflement peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surdose de mépacrine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes de surdose incluent des vertiges, des troubles de la vision et des convulsions."
}
},
{
"@type": "Question",
"name": "La mépacrine affecte-t-elle le système digestif ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut causer des troubles digestifs comme des douleurs abdominales et des diarrhées."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection nécessitent un traitement par mépacrine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs abdominales sévères et de la fièvre persistante peuvent nécessiter un traitement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections traitées par mépacrine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut des mesures d'hygiène, l'utilisation de moustiquaires et des vaccins."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines zones augmentent-ils le risque d'infection ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques augmente le risque d'infections parasitaires."
}
},
{
"@type": "Question",
"name": "Des vaccins existent-ils pour prévenir les infections ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccins sont disponibles pour certaines infections, mais pas pour toutes."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de piqûres de moustiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des répulsifs, porter des vêtements longs et installer des moustiquaires."
}
},
{
"@type": "Question",
"name": "La mépacrine peut-elle être utilisée en prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle n'est généralement pas utilisée en prévention, mais plutôt en traitement actif."
}
},
{
"@type": "Question",
"name": "Comment la mépacrine est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La mépacrine est généralement administrée par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard de mépacrine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie selon l'infection, mais elle est souvent de 100 à 200 mg par jour."
}
},
{
"@type": "Question",
"name": "La mépacrine est-elle efficace contre tous les parasites ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est principalement efficace contre certains parasites comme ceux de la leishmaniose."
}
},
{
"@type": "Question",
"name": "Peut-on combiner la mépacrine avec d'autres traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être combinée avec d'autres médicaments selon la maladie traitée."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements alternatifs à la mépacrine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des alternatives incluent l'antimoniate de méglumine et d'autres antiparasitaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la mépacrine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles hépatiques et des réactions cutanées sévères."
}
},
{
"@type": "Question",
"name": "La mépacrine peut-elle causer des problèmes hématologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des troubles sanguins comme l'anémie ou la thrombocytopénie."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des saignements inhabituels ou des douleurs abdominales sévères doivent alerter."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées à la mépacrine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'arrêt du médicament et un suivi médical approprié."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes avec la mépacrine ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares mais peuvent survenir, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent un système immunitaire affaibli, des voyages dans des zones à risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'effets secondaires ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets secondaires de la mépacrine."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies hépatiques ou sanguines augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il la réponse à la mépacrine ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que le sexe peut influencer la pharmacocinétique de la mépacrine."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions peuvent augmenter les effets secondaires ou réduire l'efficacité."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/04/2025
Contenu vérifié selon les dernières recommandations médicales
8 publications dans cette catégorie
Affiliations :
Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India. cnkundu@kiitbiotech.ac.in.
6 publications dans cette catégorie
Affiliations :
Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, USA.
6 publications dans cette catégorie
Affiliations :
Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, USA peter.madrid@sri.com sean@collaborationspharma.com.
6 publications dans cette catégorie
Affiliations :
Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India.
5 publications dans cette catégorie
Affiliations :
Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India.
Publications dans "Mépacrine" :
5 publications dans cette catégorie
Affiliations :
Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India.
Publications dans "Mépacrine" :
5 publications dans cette catégorie
Affiliations :
Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India.
Publications dans "Mépacrine" :
5 publications dans cette catégorie
Affiliations :
Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India.
Publications dans "Mépacrine" :
4 publications dans cette catégorie
Affiliations :
Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States. Electronic address: shridhar.vijayalakshmi@mayo.edu.
Publications dans "Mépacrine" :
4 publications dans cette catégorie
Affiliations :
CMBL, Department of Biological Sciences, CMBL, BITS Pilani K K Birla Goa Campus, Zuarinagar, Goa 40372, India.
Publications dans "Mépacrine" :
4 publications dans cette catégorie
Affiliations :
Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India.
Publications dans "Mépacrine" :
3 publications dans cette catégorie
Affiliations :
Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States.
Publications dans "Mépacrine" :
3 publications dans cette catégorie
Affiliations :
Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States.
Publications dans "Mépacrine" :
3 publications dans cette catégorie
Affiliations :
Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States.
Publications dans "Mépacrine" :
3 publications dans cette catégorie
Affiliations :
Division of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, United States.
Publications dans "Mépacrine" :
3 publications dans cette catégorie
Affiliations :
School of Pharmacy, Keck Graduate Institute, Claremont, CA 91711, United States.
Publications dans "Mépacrine" :
3 publications dans cette catégorie
Affiliations :
College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, United States.
Publications dans "Mépacrine" :
3 publications dans cette catégorie
Affiliations :
School of Pharmacy, Keck Graduate Institute, Claremont, CA 91711, United States; College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, United States. Electronic address: guptav@stjohns.edu.
Publications dans "Mépacrine" :
3 publications dans cette catégorie
Affiliations :
Bioscience Division, SRI International, Menlo Park, California, USA peter.madrid@sri.com sean@collaborationspharma.com.
Publications dans "Mépacrine" :
3 publications dans cette catégorie
Affiliations :
Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, North Carolina 27606, United States.
Publications dans "Mépacrine" :
During the COVID-19 pandemic, as society struggled with increasing disease burden, economic hardships, and with disease morbidity and mortality, governments and institutions began implementing stay-at...
We reviewed the literature on the effect the pandemic had on domestic violence, child and elder abuse and neglect, human trafficking, and gun violence. In this paper we explore common themes and cause...
Measures meant to help control the spread of the COVID-19 pandemic had many unintended consequences and placed people at risk for violence. Emergency departments (ED), although stressed and strained d...
The COVID-19 pandemic created delays in surgical care. The population with obesity has a high risk of death from COVID-19. Prior literature shows the most effective way to combat obesity is by weight ...
We used a preoperative evaluation tool to risk stratify bariatric patients. During a 16-month period, 89 patients were identified as low risk for outpatient surgery. We designed a postoperative protoc...
80 of 89 patients (89.8%) were successfully discharged on POD 0. 3 patients were readmitted within 30 days. We had zero deaths in our study cohort and no morbidity that would have been prevented with ...
We demonstrate that by identifying low-risk patients for outpatient bariatric surgery and by implementing remote monitoring of vitals early outpatient follow-up, we were able to safely perform outpati...
The current COVID-19 pandemic has contributed to millions of deaths globally and it is estimated that the hit to the global economy could reach more than twelve trillion US-dollars. Disease outbreaks ...
A well-researched account of the factors that drive pandemics misses an opportunity to indict broader social systems....
This article focuses on the UK's pre-COVID 19 pandemic preparedness and its early response to the COVID-19 pandemic (January '20 - March '20). The aim of this article is to explain the high excess mor...
The present study was proposed to assess if the online search behavior for Anatomy dissection was affected by actual dissection being performed in the labs. The interest in dissection was ascertained ...
Online web search behavior for key terms related to "Anatomy dissection" was noticed worldwide using Google Trends Tool. Relative search volume (RSV) was downloaded for these keywords worldwide using ...
There was almost a similar google trend for the first three months in years 2018 and 2020, with a slightly lower RSV in March and a noticeable RSV decrease from April onwards in 2020. During the pre-p...
There was lower search trend for "Anatomy dissection" during the pandemic period as compared to pre-pandemic period. The search trends may be associated with the closure of dissection labs and it may ...
The COVID-19 pandemic has served as a stark reminder that outbreaks of novel pathogens (i.e., those not previously encountered by humans) have always plagued mankind and will continue to do so. The CO...
Prior to COVID-19 pandemic, a yearly upward trajectory in the number of chlamydia infection cases was observed in South Korea. However, in response to the COVID-19 pandemic, Korea implemented several ...
Using the monthly number of reported chlamydia infection data between 2017 and 2022, we compared the trends in the reported numbers, and the incidence rates (IR) of chlamydia infection stratified by d...
We observed an irregular downward trajectory in the number of chlamydia infection in the during-pandemic period. A 30% decrease in the total number of chlamydia infection was estimated in the during-p...
We identified decrease in the number of chlamydia infection during COVID-19 pandemic which is likely due to underdiagnosis and underreporting for the infection. Therefore, strengthening surveillance f...
The COVID-19 pandemic has highlighted the importance of evidence-based clinical decision-making. Clinical management guidelines (CMGs) may help reduce morbidity and mortality by improving the quality ...
Ovid Medline, Ovid Embase, TRIP (Turning Research Into Practice), and Guideline Central were searched systematically from January 2008 to 23rd June 2022, complemented by a grey literature search till ...
Forty-eight CMGs were included. They were produced in high- (42%, 20/48), upper-middle- (40%, 19/48), and lower-middle (8%, 4/48) income countries, or by international organisations (10%, 5/48). Most ...
Our data highlights the limited availability of up-to-date pandemic influenza CMGs globally. Of those identified, many were limited in scope and quality and several lacked recommendations for specific...
Health authorities have highlighted "pandemic fatigue" as a psychological consequence of the COVID-19 pandemic and warned that "fatigue" could demotivate compliance with health-related policies and ma...